Institutions were ranked based on their involvement in agentic AI systems for rare disease diagnosis, including clinical trial activity, research programs, recent publications, and recognition by U.S. News & World Report.
#1
Baylor College of Medicine and Texas Children’s Hospital
Houston, TX
Baylor/Texas Children’s leads in NIH rare-disease infrastructure and publishes impactful agentic AI systems for Mendelian diagnostics.
Key Differentiators
Rare Disease Medicine
#2
Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital
Nashville, TN
Vanderbilt combines UDN case work with innovative LLM studies to enhance diagnostic workflows for rare diseases.
Key Differentiators
Rare Disease Medicine
#3
Boston Children’s Hospital and Harvard Medical School
Boston, MA
Boston Children’s excels in integrating AI/LLM pipelines for rare disease phenotyping and management.
Key Differentiators
Rare Disease Medicine
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.